Millennium Management
AGIO icon

Millennium Management’s Agios Pharmaceuticals AGIO Stock Holding History

Millennium Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,000
Closed -$544K – 5647
2025
Q4 		$544K Buy
+20,000
New +$702K ﹤0.01% 4888
2017
Q1 		– Sell
-50,000
Closed -$2.09M – 3448
2016
Q4 		$2.09M Buy
+50,000
New +$2.62M ﹤0.01% 1853

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Millennium Management's AGIO Position: Q1 2026 in Review

Millennium Management reduced its Agios Pharmaceuticals (AGIO) stake by 92% in Q1 2026, selling an estimated $10.4M and leaving 32,144 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #4328.

Millennium Management first reported a position in AGIO in Q1 2014 and has held it in 37 quarters since. The position peaked at $35.2M in Q1 2016. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Millennium Management held 32,144 shares of Agios Pharmaceuticals worth $1.09M as of Q1 2026.
  • Millennium Management sold 366,123 Agios Pharmaceuticals shares in Q1 2026, an estimated $10.4M.
  • Agios Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4328 holding.
  • Millennium Management first reported a position in Agios Pharmaceuticals in Q1 2014 and has held it in 37 quarters since.
  • Millennium Management's Agios Pharmaceuticals position peaked at $35.2M in Q1 2016.
  • 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.